Solventum Corporation (SOLV)

Healthcare · Medical Instruments Supplies · NYSE

S&P 500

Solventum Corporation (SOLV) is a Healthcare company in the Medical Instruments Supplies industry. It has a market capitalization of $15.11B, a trailing price-to-earnings ratio of 12.5 and a free-cash-flow yield of -0.1%. Over the most recent reported fiscal year, revenue grew 0.9% and free cash flow per share fell 101.2%.

Market cap	$15.11B
Trailing P/E	12.5
FCF yield	-0.1%
Revenue growth (YoY)	+0.9%
EPS growth (YoY)	-8.8%
FCF/share growth (YoY)	-101.2%
Exchange	NYSE
Sector	Healthcare
Industry	Medical Instruments Supplies

Explore live SOLV data on Nama Insights →

Recent Congressional trades

Solventum Corporation trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Thomas H Tuberville	Senate	Sell	$1,001 - $15,000	Aug 5, 2026
Thomas H Tuberville	Senate	Sell	$1,001 - $15,000	Aug 5, 2026
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
James French Hill	House	Sell	$15,001 - $50,000	Jan 23, 2026
Julie Johnson	House	Sell	$1,001 - $15,000	Feb 12, 2025